Dalton, Greiner, Hartman, Maher & Co’s Innospec IOSP Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-28,295	Closed	-$1.32M	–	191
2015 Q3	$1.32M	Sell	28,295 -243	-0.9%	-$11.1K	0.07%	139
2015 Q2	$1.28M	Buy	28,538 +517	+2%	+$23.2K	0.07%	153
2015 Q1	$1.3M	Sell	28,021 -687	-2%	-$29.5K	0.07%	147
2014 Q4	$1.23M	Buy	28,708 +604	+2%	+$24.8K	0.07%	152
2014 Q3	$1.01M	Buy	28,104 +160	+0.6%	+$6.5K	0.06%	164
2014 Q2	$1.21M	Sell	27,944 -1,209	-4%	-$52.1K	0.06%	148
2014 Q1	$1.32M	Sell	29,153 -2,036	-7%	-$89.7K	0.08%	142
2013 Q4	$1.44M	Buy	31,189 +794	+3%	+$36.4K	0.08%	135
2013 Q3	$1.42M	Sell	30,395 -150	-0.5%	-$6.46K	0.1%	132
2013 Q2	$1.23M	Buy	+30,545	New	+$1.27M	0.09%	135

Other funds holding IOSP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HCM

Huber Capital Management El Segundo, California $679M AUM 25.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's IOSP Position: Q4 2015 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Innospec (IOSP) in Q4 2015, closing a stake of 28,295 shares — an estimated $1.32M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in IOSP in Q2 2013 and held it in 10 quarters. The position peaked at $1.44M in Q4 2013. 196 funds tracked by Wall St. Rank hold IOSP as of Q4 2015.

Dalton, Greiner, Hartman, Maher & Co reported no remaining Innospec position as of Q4 2015 after selling out during the quarter.
Dalton, Greiner, Hartman, Maher & Co sold 28,295 Innospec shares in Q4 2015, an estimated $1.32M.
Dalton, Greiner, Hartman, Maher & Co first reported a position in Innospec in Q2 2013 and held it in 10 quarters.
Dalton, Greiner, Hartman, Maher & Co's Innospec position peaked at $1.44M in Q4 2013.
196 funds tracked by Wall St. Rank held Innospec as of Q4 2015.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q4 2015, filed 14 Jan 2016.